Guides confirmation testing for short-chain acyl-CoA dehydrogenase (SCAD) deficiency detected by newborn screening, using plasma butyrylcarnitine (C4) levels, ACADS gene variant pathogenicity, and clinical correlation.
Guides confirmation testing for short-chain acyl-CoA dehydrogenase (SCAD) deficiency detected by newborn screening, using plasma butyrylcarnitine (C4) levels, ACADS gene variant pathogenicity, and clinical correlation
Each component has a specific meaning:
Note: Interpret the scad deficiency result against the thresholds and context described above.
Enter the plasma butyrylcarnitine levels, ACADS gene variant pathogenicity, clinical correlation for the scenario you are assessing. Guides confirmation testing for short-chain acyl-CoA dehydrogenase (SCAD) deficiency detected by newborn screening, using plasma butyrylcarnitine (C4) levels, ACADS gene variant pathogenicity, and clinical correlation. Use the scad deficiency result to inform your calculation.